This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Asociacion Civil De Estudios Superiores (Aces), Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Conicet), Fundacion Instituto Leloir (Fil). Active years: 2019.
Company Filing History:
1 out of 1 
1 out of 81 
1 out of 1 
Years Active: 2019
Title: Jorge Aquino: Innovator in Liver Therapeutics
Introduction
Jorge Aquino is a notable inventor based in Provincia de Buenos Aires, Argentina. He has made significant contributions to the field of liver therapeutics, particularly through his innovative research and patenting efforts. His work focuses on addressing critical health issues such as acute liver failure and fulminant hepatitis.
Latest Patents
Jorge Aquino holds a patent for SPARC (Secreted Protein, Acidic and Rich in Cysteine), which serves as a new target for the treatment and prevention of acute liver failure. This invention identifies SPARC as a therapeutic target in patients suffering from fulminant hepatitis. The patent outlines a strategy aimed at protecting the liver from damage by administering agents that inhibit the expression of SPARC or interfere with its biological function. He has 1 patent to his name.
Career Highlights
Throughout his career, Jorge has worked with various organizations, including Inis Biotech LLC and the National Scientific and Technical Research Council (CONICET). His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Jorge has collaborated with esteemed colleagues such as Guillermo Daniel Mazzolini and Estanislao Peixoto. These partnerships have enriched his research and fostered innovation in the field of liver health.
Conclusion
Jorge Aquino's work in identifying SPARC as a therapeutic target represents a significant advancement in the treatment of liver diseases. His contributions continue to impact the medical field positively, paving the way for future innovations in liver therapeutics.